Cargando…

Pharmaceutical companies’ views on a health technology assessment (HTA) entity in Saudi Arabia

Saudi Arabia is undergoing a massive healthcare transformation to fulfill its new, national “Vision 2030.” To align with this objective, Saudi Arabia is establishing a new, independent and evidence-based health technology assessment (HTA) entity to help it maximize health gains through efficient use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Omar, Hussain Abdulrahman, Attuwaijri, Abdulaziz Abdulhadi, Aljuffali, Ibrahim Abdulrahman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292859/ https://www.ncbi.nlm.nih.gov/pubmed/32550796 http://dx.doi.org/10.1016/j.jsps.2020.04.006

Ejemplares similares

Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop
por: Al-Omar, Hussain A., et al.
Publicado: (2021)

Views and Perceptions of Medical Representatives and Physicians about the Role of Medical Representatives and Pharmaceutical Advertisement in Saudi Arabia – A Pilot Study
por: Faqeh, Sultan, et al.
Publicado: (2023)

Pharmaceutical Care in the Community Pharmacies of Saudi Arabia: Present Status and Possibilities for Improvement
por: Alanazi, Abdulrahman S., et al.
Publicado: (2016)

The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)

PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities
por: Thomas, M., et al.
Publicado: (2020)

Anxiety and Stress among Day Traders in Saudi Arabia
por: Bin Abdulrahman, Khalid A., et al.
Publicado: (2022)

Localizing pharmaceuticals manufacturing and its impact on drug security in Saudi Arabia
por: Tawfik, Essam A., et al.
Publicado: (2022)

The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore
por: Hashan, Hajed, et al.
Publicado: (2015)

Comparison of the Nutritional Values of Infant Formulas Available in Saudi Arabia
por: Almazrooy, Abdulhadi Hesn, et al.
Publicado: (2017)

Pediatric Stroke from Bench to Bedside: A Single-Center Experience in Saudi Arabia
por: Al-Sharydah, Abdulaziz Mohammad, et al.
Publicado: (2022)

Parents’ Knowledge, Attitude, and Practice Regarding Febrile Convulsion in Children in Riyadh, Saudi Arabia
por: Almousa, Abdulaziz, et al.
Publicado: (2023)

Households’ Direct Economic Burden Associated with Chronic Non-Communicable Diseases in Saudi Arabia
por: Almalki, Ziyad S., et al.
Publicado: (2022)

Impact of Clinical Pharmacist Running Anticoagulation Clinic in Saudi Arabia
por: Alshaiban, Abdulrahman, et al.
Publicado: (2023)

Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company
por: Ducournau, Pierre, et al.
Publicado: (2019)

Effect of Phaseolus Vulgaris on Urinary Biochemical Parameters among Patients with Kidney Stones in Saudi Arabia
por: Jalal, Sahbanathul Missiriya, et al.
Publicado: (2020)

Interactions between physicians and pharmaceutical sales representatives in Saudi Arabia
por: Alosaimi, Fahad Dakheel, et al.
Publicado: (2013)

National medicines policy development, Saudi Arabia
por: Almoteiry, Khalid, et al.
Publicado: (2022)

Double diabetes in Saudi Arabia: A new entity or an underestimated condition
por: Braham, Rim, et al.
Publicado: (2016)

Assessment of Consistency between Claims and References Referred to in Pharmaceutical Advertising Brochures in the Kingdom of Saudi Arabia
por: Al-Tuhaifi, Tareq M, et al.
Publicado: (2019)

SERO-PREVALENCE OF TOXOPLASMOSIS IN PREGNANT MOTHERS AND NEW BORN INFANTS IN EASTERN PROVINCE, SAUDI ARABIA
por: Al-Mulhim, Abdulaziz A., et al.
Publicado: (2001)

Type 1 Diabetes Mellitus in Saudi Arabia: A Soaring Epidemic
por: Robert, Asirvatham Alwin, et al.
Publicado: (2018)

Prevalence and Characteristics of Knee Osteoarthritis Among the General Public in Saudi Arabia
por: Bashekah, Kadejh Abdulrahman, et al.
Publicado: (2023)

HIV-associated nephropathy in Saudi Arabia
por: Al-Sheikh, Haifa, et al.
Publicado: (2013)

Risk factors for amputation in extremity vascular injuries in Saudi Arabia
por: Al Wahbi, Abdullah, et al.
Publicado: (2016)

Current status and vision of local pharmaceutical industries in Saudi Arabia: The focus on nanomedicines
por: Halwani, Abdulrahman A., et al.
Publicado: (2023)

Hydroxyurea usage awareness among patients with sickle‐cell disease in Saudi Arabia
por: Alsalman, Mortadah, et al.
Publicado: (2021)

Patient Satisfaction After Conservative Treatment for Burn Scars in Saudi Arabia
por: Almodumeegh, Abdulaziz S, et al.
Publicado: (2022)

Contact Lens Practices and Knowledge of Complications and its Association With Refractive Error in Saudi Arabia
por: Alzahrani, Othman, et al.
Publicado: (2021)

Parents’ perception of children's obesity, in Al-Qassim, Saudi Arabia
por: Al-Mohaimeed, Abdulrahman A.
Publicado: (2016)

Physicians' Knowledge and Attitude towards Mental Health in Saudi Arabia
por: Al-Atram, Abdulrahman A
Publicado: (2018)

Prevalence, Predictors and Point of View Toward Self-Medication Among Residents of Riyadh, Saudi Arabia: A Cross-Sectional Study
por: Mannasaheb, Basheerahmed Abdulaziz, et al.
Publicado: (2022)

Prevalence and severity of dyspepsia in Saudi Arabia: A survey-based study
por: Alwhaibi, Abdulrahman, et al.
Publicado: (2020)

Gamma radiation and indoor radon concentrations in the western and southwestern regions of Saudi Arabia
por: Alghamdi, Abdulrahman S., et al.
Publicado: (2019)

Prevalence of post-COVID symptoms of obsessive-compulsive disorder in Saudi Arabia
por: Alblowi, Mohammed A., et al.
Publicado: (2023)

Serum heavy metals and hemoglobin related compounds in Saudi Arabia firefighters
por: Al-Malki, Abdulrahman L
Publicado: (2009)

“Is there a doctor on board?”: willingness and confidence of physicians in the Kingdom of Saudi Arabia in assisting with in-flight medical emergencies
por: AlShamlan, Nouf A., et al.
Publicado: (2021)

Exploring physicians’ prescribing behavior in patients with multiple sclerosis in Saudi Arabia: a sequential explanatory mixed-methods
por: Al-Omar, Hussain Abdulrahman, et al.
Publicado: (2023)

Preferred Method of Education Among Patients in Ophthalmic Care in Saudi Arabia
por: AlHilali, Sara M., et al.
Publicado: (2016)

The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
por: Arpinelli, Fabio, et al.
Publicado: (2006)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9l5idt42qli2ftdlppg7107614